CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Operating Income Growth by Quarter and Year

Atara Biotherapeutics Inc 's Operating Income results by quarter and year




ATRA Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December -92.04 -81.82 -35.80 -18.75
III Quarter September -72.56 -60.22 -31.66 -25.94
II Quarter June -75.54 -52.62 -27.91 -19.49
I Quarter March -67.89 -42.45 -26.16 -17.06
FY   -308.03 -237.11 -121.53 -81.24



ATRA Operating Income forth quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics Inc in the forth quarter recorded Operating Loss of $ -92.04 millions.

According to the results reported in the forth quarter, Atara Biotherapeutics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the forth quarter.

Explain Operating Income growth


ATRA Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's forth quarter 2018 Operating Income $ -92.04 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's forth quarter 2017 Operating Income $ -81.82 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Operating Income Growth >>


ATRA Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Atara Biotherapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Operating Income Comment
Recent results of -92.04 millions by Atara Biotherapeutics Inc appear even more unfavourable considering the Operating Loss -72.56 millions in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Operating Income growth. While Atara Biotherapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Operating Income Comment
Current Operating Loss of -92.04 millions by Atara Biotherapeutics Inc come out even less good considering the Operating Loss -72.56 millions in the third quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Operating Income growth. While Atara Biotherapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -317.28 $ -297.80 $ -285.46 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -317 millions in the Dec 31 2019 period.
The results are worsening as the cumulative Operating Loss is inflating from $ -285.46 millions in TTM ending quarter Sep 30 2019 and $ -72.56 millions for the twelve months ending in the quarter a year ago Marea Lombardi mentioned.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months Operating Loss of $ -317 millions in the Dec 31 2019 period.
The situation is worsening as the cumulative Operating Loss is getting bigger from $ -285.46 millions for the period from Sep 30 2019 to and $ -72.56 millions for the twelve months ending in the quarter a year ago.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ATRA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ATRA's Competitors
Operating Income Growth for Atara Biotherapeutics Inc 's Suppliers
Operating Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2019
Acorda Therapeutics inc   21.79 %$ 21.793 millions
Intuitive Surgical Inc   19.76 %$ 19.759 millions
Davita Inc   19.25 %$ 19.252 millions
Abbott Laboratories  19.23 %$ 19.227 millions
West Pharmaceutical Services Inc   18.69 %$ 18.693 millions
Hanger Inc   18.14 %$ 18.137 millions
Medpace Holdings inc   17.78 %$ 17.779 millions
Icon Plc  16.08 %$ 16.084 millions
Incyte Corporation  15.90 %$ 15.899 millions
Zoetis Inc   15.31 %$ 15.311 millions
Chemed Corporation  14.95 %$ 14.946 millions
Biospecifics Technologies Corp  14.55 %$ 14.550 millions
Amedisys Inc   14.11 %$ 14.110 millions
Tenet Healthcare Corp  13.86 %$ 13.861 millions
Catalent Inc   13.81 %$ 13.811 millions
Boston Scientific Corporation  13.79 %$ 13.793 millions
Abiomed Inc  12.68 %$ 12.676 millions
China Biologic Products Holdings Inc   11.96 %$ 11.955 millions
Bruker Corporation  11.78 %$ 11.776 millions
Insulet Corporation  11.67 %$ 11.674 millions
Stryker Corp  11.45 %$ 11.452 millions
Hill rom Holdings Inc   11.44 %$ 11.441 millions
Novartis Ag  11.23 %$ 11.225 millions
Bio techne Corp  10.09 %$ 10.085 millions
Redhill Biopharma Ltd   9.84 %$ 9.840 millions
Biogen Inc   9.68 %$ 9.681 millions
Laboratory Corp Of America Holdings  9.33 %$ 9.327 millions
Henry Schein Inc  9.30 %$ 9.296 millions
Teleflex Incorporated  6.43 %$ 6.428 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ANDR's Profile

Stock Price

ANDR's Financials

Business Description

Fundamentals

Charts & Quotes

ANDR's News

Suppliers

ANDR's Competitors

Customers & Markets

Economic Indicators

ANDR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071